顶部联系方式

Time of issue:2019-09-22 00:00:00
EN
SEARCH
Confirm
Cancel

HUAPONT PHARM

NEWS

Winning the bidding from centralised procurement
Check category

Winning the bidding from centralised procurement

  • Categories:2020
  • Author:
  • Origin:
  • Time of issue:2020-09-22 08:38
  • Views:0

【Summary】In order to cut drug prices low enough, China had been pushing forward a system that requires drug manufacturers to go through a bidding process and cut prices low enough if they want to sell their products at public hospitals via large-volume government procurement.

In the last 3 bidding processing, Chongqing Huapont pharm Co., Ltd.’s products: Moxifloxacin tablet, Anastrozole tablet and Levocetirizine HCL tablet were successful won in the centralised procurement process.

Centralised Procurement History:

1st Round: start from 2019 December 15th, total of 25 medicines were open for bidding, covering 11 provinces and regions;

2nd Round: start from 2020 January 17th, total of 33 medicines were open for bidding, covering 23 provinces and regions;

3rd Round: start from 2020 August 20th, total of 56 medicines were open for bidding, covering 25 provinces and regions;

Winning the bidding from centralised procurement

【Summary】In order to cut drug prices low enough, China had been pushing forward a system that requires drug manufacturers to go through a bidding process and cut prices low enough if they want to sell their products at public hospitals via large-volume government procurement.

In the last 3 bidding processing, Chongqing Huapont pharm Co., Ltd.’s products: Moxifloxacin tablet, Anastrozole tablet and Levocetirizine HCL tablet were successful won in the centralised procurement process.

Centralised Procurement History:

1st Round: start from 2019 December 15th, total of 25 medicines were open for bidding, covering 11 provinces and regions;

2nd Round: start from 2020 January 17th, total of 33 medicines were open for bidding, covering 23 provinces and regions;

3rd Round: start from 2020 August 20th, total of 56 medicines were open for bidding, covering 25 provinces and regions;

  • Categories:2020
  • Author:
  • Origin:
  • Time of issue:2020-09-22 08:38
  • Views:0
Information

In order to cut drug prices low enough, China had been pushing forward a system that requires drug manufacturers to go through a bidding process and cut prices low enough if they want to sell their products at public hospitals via large-volume government procurement.

In the last 3 bidding processing, Chongqing Huapont pharm Co., Ltd.’s products: Moxifloxacin tablet, Anastrozole tablet and Levocetirizine HCL tablet were successful won in the centralised procurement process.

Centralised Procurement History:

1st Round: start from 2019 December 15th, total of 25 medicines were open for bidding, covering 11 provinces and regions;

2nd Round: start from 2020 January 17th, total of 33 medicines were open for bidding, covering 23 provinces and regions;

3rd Round: start from 2020 August 20th, total of 56 medicines were open for bidding, covering 25 provinces and regions;

Keyword:

Scan the QR code to read on your phone

Bangbang Bird

QUICK LINKS

Quick Links

Time of issue:2020-05-28 00:00:00

CONTACT INFO

Contact Info

Time of issue:2020-05-28 00:00:00

TEL: +86-23-67886927

TEL: +86-23-67886928

EMAIL: api@huapont.cn

ADD.: No.69 Xingguang Avenue, Renhe Town, Yubei District,Chongqing, China 401121

FEEDBACK

留言应用名称:
feedback
Description:
验证码

地址版权

Time of issue:2019-09-22 00:00:00

© 2020 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved. Powered by: www.300.cn 渝ICP备05003324号

手机版地址版权

Time of issue:2019-09-22 00:00:00

© 2020 Chongqing Huapont Pharmaceutical Co., Ltd.

Powered by: www.300.cn 渝ICP备05003324号